These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 2250979)
1. The use of nimodipine (Nimotop-Bayer) in patients with chronic ischemic cerebral vasculopathies. Twenty-eight case reports. Politi GC; Romanini BM; Belloli PA; Rossi A; Bellaviti N; Pucci C; Ferro C Panminerva Med; 1990; 32(2):85-7. PubMed ID: 2250979 [TBL] [Abstract][Full Text] [Related]
2. [Nimodipine in ischemic cerebropathy]. Di Lascio G; Salvini S Clin Ter; 1993 Feb; 142(2):123-6. PubMed ID: 8472525 [TBL] [Abstract][Full Text] [Related]
3. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025 [TBL] [Abstract][Full Text] [Related]
4. [The use of nimodipine in comatose patients with different types of cerebrovascular pathology]. Alia G; Mattaliano A Clin Ter; 1993 Oct; 143(4):295-301. PubMed ID: 8258263 [TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke. Nag D; Garg RK; Varma M Indian J Physiol Pharmacol; 1998 Oct; 42(4):555-8. PubMed ID: 10874361 [TBL] [Abstract][Full Text] [Related]
6. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884 [TBL] [Abstract][Full Text] [Related]
7. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders. Di Mascio R; Marchioli R; Tognoni G Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186 [TBL] [Abstract][Full Text] [Related]
8. Use of calcium channel blockers in acute ischemic cerebrovascular disease. Dalal PM; Dalal KP J Assoc Physicians India; 1995 Jun; 43(6):394-7. PubMed ID: 8906943 [TBL] [Abstract][Full Text] [Related]
9. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy. Hänggi D; Beseoglu K; Turowski B; Steiger HJ Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777 [TBL] [Abstract][Full Text] [Related]
10. [Effects of nimodipine on mental deterioration in subjects with chronic cerebrovascular pathology]. Canadè V; Catapano F; Muraca L; Cosentino A Minerva Med; 1991 Mar; 82(3):111-4. PubMed ID: 2006028 [TBL] [Abstract][Full Text] [Related]
11. [Does nimodipine improve the outcome of perioperative complications of aneurysm rupture? Results of systematic treatment]. Ades PE; Fabre M; Aesch B; Rieant JF; Buchet S; Lamotte C; Jan M Agressologie; 1989 Jun; 30(7):431-6. PubMed ID: 2817239 [TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic profile in patients presenting with cerebral arterial spasm after meningeal hemorrhage in the presence of preventive administration of i.v. nimodipine]. Adnet P; Fesard P; Riegel B; Runge I; Lejeune JP; Krivosic-Horber R Ann Fr Anesth Reanim; 1989; 8 Suppl():R84. PubMed ID: 2604269 [No Abstract] [Full Text] [Related]
13. [The use of the preparation Nimotop in neurosurgical patients]. Amcheslavskiĭ VG; Demchuk ML; Madorskiĭ SV; Toma GI; Margishvili GM; Fokin MS; Savin IA Zh Vopr Neirokhir Im N N Burdenko; 1997; (3):41-3. PubMed ID: 9424955 [No Abstract] [Full Text] [Related]